Vivici Secures €32.5M to Expand Its Precision Fermentation-Derived Dairy Proteins

Dutch startup Vivici has secured €32.5 million in funding to expand its precision fermentation-derived dairy proteins. The Series A funding round was led by APG and Invest-NL, with participation from InnovationQuarter, dsm-firmenich, and Fonterra. The company plans to use the funding to enter new markets, launch a second dairy protein ingredient, and establish long-term manufacturing capabilities.

Vivici's first ingredient, ViviteinTM BLG, is targeted at consumers in the active nutrition category and can be used in products like protein drinks and vegan-friendly bars. The company also has plans to launch other ingredient products, with lactoferrin, ViviteinTM LF, set to debut in 2025. Through its precision fermentation platform, ViviteinTM, Vivici aims to bring a new standard of protein to the market and revolutionize consumer protein products.